MedPath

Influence of the microalgae Chlorella sorokiniana on microbiome-host interactions in humans

Not Applicable
Recruiting
Conditions
Healthy participants
Registration Number
DRKS00033648
Lead Sponsor
Technische Universität München, ZIEL - Institute for Food and Health, Lehrstuhl für Ernährung und Immunologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
75
Inclusion Criteria

Written declaration of consent; omnivore, vegetarian, vegan diet

Exclusion Criteria

Missing informed consent; current participation in another intervention study; known allergies or intolerances to Chlorella sorokiniana, the tested foods, mold, brillant blue FCF (E 133) or riboflavin (E 101); pregnancy or breastfeeding; body mass index below 18.5 or above 30 kg/m^2; special diets (low-carb, high-fat, formula, protein-supplemented, etc.); antibiotic treatment in the 6 months prior to the start of the study; diverticulitis; inflammatory bowel disease (ulcerative colitis, Crohn's disease); use of anticoagulants; pacemaker patients

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The changes in the composition of the microbiota of the participants after consumption of foods containing Chlorella sorokiniana (intact or broken cell wall) are the primary endpoint of the study. To investigate this, stool samples are collected from the subjects throughout the study. This is done during the one-week wash-in phase, during the two-week intervention phase in which the bread rolls are consumed, and during the subsequent four-week follow-up phase. The stool samples are then examined using bacterial sequencing to assess any changes in the microbiota composition based on the sequencing results. The primary aim is to analyze the increase in bacterial diversity in the intestines of the participants after the consumption of foods enriched with Chlorella sorokiniana.
Secondary Outcome Measures
NameTimeMethod
As a secondary endpoint of this study, the influence of the study foods on the metabolite profile in the intestines and blood of the participants will be examined to identify metabolic changes. For this purpose, the stool samples collected at the end of each phase (wash-in, intervention, follow-up) are analyzed for various metabolites (short-chain fatty acids, bile acids) using mass spectrometry. In addition, a blood sample is taken at the end of each phase. These blood samples are also analyzed for metabolites.
© Copyright 2025. All Rights Reserved by MedPath